semaglutide in heart failure patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for or all-cause mortality compared to sitagliptin, but tirzepatide offered no additional benefit over semaglutide. #ESCCongress Semaglutide and the Heart: Focus

42 The ARC contains two distinct neuron types with opposing functions

The Discontinuation Problem Nobody Talks About Clinical trials for GLP-1 medications show promising results, with patients losing 15-21% of their excess body weight

Vial size and reconstitution volume together determine the final concentration, which determines the syringe volume for each target dose

Mounjaro is the latest GLP1 treatment, and is even more effective than Ozempic for weight loss

There is also an issue of medication shortages: if you are unable to obtain semaglutide, it may be worthwhile discussing with your doctor alternative treatment options, including switching to a different weight loss medication